Stella Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 5, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	15,996	13,035	9,087	11,485	17,281	-
Market Cap Growth	5.62%	43.45%	-20.88%	-33.54%	-	-
Enterprise Value	14,091	10,396	7,501	10,146	14,767	-
Last Close Price	470.00	383.00	291.00	387.00	603.00	-
PS Ratio	16.52	13.56	33.78	50.15	172.82	-
PB Ratio	5.94	4.07	3.82	4.17	5.61	-
P/TBV Ratio	6.03	4.13	3.91	4.27	5.74	-
P/FCF Ratio	-	95.85	-	-	-	-
P/OCF Ratio	-	93.11	-	-	-	-
EV/Sales Ratio	14.56	10.82	27.88	44.31	147.68	-
EV/FCF Ratio	-	76.44	-	-	-	-
Debt / Equity Ratio	0.29	0.24	0.39	0.40	0.41	6.14
Debt / FCF Ratio	-	5.63	-	-	-	-
Net Debt / Equity Ratio	-0.71	-0.76	-0.60	-0.59	-0.66	0.70
Net Debt / EBITDA Ratio	9.78	43.57	1.96	2.10	2.86	-0.25
Net Debt / FCF Ratio	-	-17.94	1.60	1.90	1.80	-0.20
Asset Turnover	0.20	0.21	0.07	0.05	0.03	0.09
Inventory Turnover	0.10	0.10	0.05	0.03	0.03	0.07
Quick Ratio	13.21	10.05	5.34	6.58	10.69	4.09
Current Ratio	18.77	13.44	7.98	9.01	13.56	5.67
Return on Equity (ROE)	-9.84%	-5.01%	-29.76%	-26.68%	-46.36%	-143.26%
Return on Assets (ROA)	-2.89%	-1.22%	-11.66%	-11.14%	-13.69%	-18.08%
Return on Capital Employed (ROCE)	-5.00%	-1.80%	-22.60%	-20.60%	-16.80%	-39.40%
Earnings Yield	-1.74%	-1.07%	-8.40%	-6.77%	-4.44%	-
FCF Yield	-	1.04%	-9.75%	-7.43%	-6.52%	-
Buyback Yield / Dilution	-4.11%	-7.76%	-7.27%	-2.83%	-40.17%	-28.43%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.